Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 50 | 0 | 5 | 0 | €701.10 | €760.00 | 8.401% |
Biogen Inc. | 46 | 1 | 6 | 1 | €209.70 | €294.01 | 40.205% |
Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €399.00 | €408.36 | 2.345% |
Regeneron Pharmaceuticals Inc. | 34 | 1 | 4 | 0 | €905.80 | €957.22 | 5.677% |
Johnson & Johnson | 32 | 1 | 3 | 0 | €140.06 | €196.74 | 40.465% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €120.00 | €124.93 | 4.108% |
Pfizer Inc. | 31 | 4 | 3 | 0 | €26.38 | €40.66 | 54.159% |
Amgen Inc. | 25 | 0 | 5 | 0 | €287.55 | €297.31 | 3.395% |
Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.06 | €200.06 | 28.193% |
AbbVie Inc. | 21 | 0 | 4 | 0 | €150.00 | €174.43 | 16.289% |
BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €74.46 | €102.62 | 37.818% |
Abbott Laboratories | 16 | 0 | 2 | 0 | €97.32 | €116.81 | 20.024% |
Exact Sciences | 13 | 0 | 2 | 0 | €51.01 | €82.63 | 61.989% |
Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.76 | €86.77 | 38.258% |
Incyte Corp. | 12 | 2 | 3 | 0 | €54.50 | €78.42 | 43.894% |
Elanco Animal Health Inc. | 7 | 3 | 1 | 0 | €15.68 | €15.58 | -0.643% |
Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.15 | €130.00 | 6.427% |